WuXi Biologics Receives ESG Corporate Platinum Award From The Asset for Fourth Consecutive Year

PR NewswireOct 16 08:00 ET

WuXi Biologics Receives ESG Corporate Platinum Award From The Asset for Fourth Consecutive Year

HONG KONG, Oct. 16, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has

PR NewswireOct 16 08:00 ET

Trending Industry Today: WUXI APPTEC Leads Losses In Biotechnology Stocks

Moomoo NewsOct 15 03:10 ET

Trending Industry Today: TIGERMED Leads Losses In CRO Stocks

Moomoo NewsOct 13 23:00 ET

Trending Industry Today: WUXI XDC Leads Losses In Biotechnology Stocks

Moomoo NewsOct 8 23:10 ET

Wuxi Bio (02269.HK) spent 49.765 million Hong Kong dollars on October 8 to buy back 2.53 million shares.

Gelonghui October 8th | wuxi bio (02269.HK) announced that on October 8th, it spent 49.765 million Hong Kong dollars to repurchase 2.53 million shares.

Gelonghui FinanceOct 8 09:47 ET